Immune-Escape Mutations Are Prevalent among Patients with a Coexistence of HBsAg and Anti-HBs in a Tertiary Liver Center in the United States
Viruses · 30.04.2024 · 16 (5) · 713
DOI: 10.3390/v16050713 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 30.04.2024. Verfasst von Mukarram Jamat Ali und 7 weiteren Autor:innen. Beteiligte Einrichtung: Liver Center, Division of Gastroenterology and Hepatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Bost…. Hauptthemen laut MEDLINE: Hepatitis B Surface Antigens, Hepatitis B virus, Mutation, Hepatitis B Antibodies. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The concurrent seropositivity of HBsAg and anti-HBs has been described among patients with chronic hepatitis B (CHB), but its prevalence is variable. HBV S-gene mutations can affect the antigenicity of HBsAg. Patients with mutations in the ‘α’ determinant region of the S gene can develop severe HBV reactivation under immunosuppression. In this study at a tertiary liver center in the United States, we evaluated the frequency and virological characteristics of the HBsAg mutations among CHB patients with the presence of both HBsAg and anti-HBs. In this cohort, 45 (2.1%) of 2178 patients were identified to have a coexistence of HBsAg and anti-HBs, and 24 had available sera for the genome analysis of the Pre-S1, Pre-S2, and S regions. The frequency of mutations in the S gene was significantly higher among those older than 50 years (mean 8.5 vs. 5.4 mutations per subject, p = 0.03). Twelve patients (50%) had mutations in the ‘α‘ determinant region of the S gene. Mutations at amino acid position 126 were most common in eight subjects. Three had a mutation at position 133. Only one patient had a mutation at position 145—the classic vaccine-escape mutation. Despite the universal HBV vaccination program, the vaccine-escape mutant is rare in our cohort of predominantly Asian patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Liver Center, Division of Gastroenterology and Hepatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
- Howard University Hospital, Howard University College of Medicine, Washington, DC 20060, USA.
- Abbott Diagnostics Division, Abbott Laboratories, Abbott Park, IL 60064, USA.
ORCID-Profile: Vera Holzmayer
Zitieren
APA
Ali, M. J., Shah, P. A., Rehman, K. U., Kaur, S., Holzmayer, V., Cloherty, G. A., Kuhns, M. C., & Lau, D. T. Y. (2024). Immune-Escape Mutations Are Prevalent among Patients with a Coexistence of HBsAg and Anti-HBs in a Tertiary Liver Center in the United States. Viruses, 16(5), 713. https://doi.org/10.3390/v16050713
Vancouver
Ali MJ, Shah PA, Rehman KU, Kaur S, Holzmayer V, Cloherty GA, et al. Immune-Escape Mutations Are Prevalent among Patients with a Coexistence of HBsAg and Anti-HBs in a Tertiary Liver Center in the United States. Viruses. 2024;16(5):713. doi:10.3390/v16050713
BibTeX
@article{Ali2024,
author = {Ali, Mukarram Jamat and Shah, Pir Ahmed and Rehman, Khalil Ur and Kaur, Satinder and Holzmayer, Vera and Cloherty, Gavin A and Kuhns, Mary C and Lau, Daryl T Y},
title = {Immune-Escape Mutations Are Prevalent among Patients with a Coexistence of HBsAg and Anti-HBs in a Tertiary Liver Center in the United States},
journal = {Viruses},
year = {2024},
volume = {16},
number = {5},
pages = {713},
doi = {10.3390/v16050713}
}
EUVIMED